From: Max More (max@maxmore.com)
Date: Thu Dec 16 1999 - 14:39:26 MST
Rather unusually for a biotech IPO, today Maxygen went public very
successfully. They are using directed molecular evolution. The founder has
also co-founded several other successful companies including Affymetrix.
Full story:
http://www.cnbc.com/commentary/commentary_full_story_stocks.asp?StoryID=9836
Max
This archive was generated by hypermail 2.1.5 : Fri Nov 01 2002 - 15:06:06 MST